BDHIX
Price
$9.09
Change
+$0.01 (+0.11%)
Updated
Jun 2 closing price
Net Assets
1.6B
CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
Interact to see
Advertisement

BDHIX vs CIMCX

Header iconBDHIX vs CIMCX Comparison
Open Charts BDHIX vs CIMCXBanner chart's image
BDHIX vs CIMCX Comparison Chart in %
View a ticker or compare two or three
VS
BDHIX vs. CIMCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDHIX is a Buy and CIMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. BDHIX (1.6B). BDHIX pays higher dividends than CIMCX: BDHIX (7.59) vs CIMCX (2.73). BDHIX was incepted earlier than CIMCX: BDHIX (12 years) vs CIMCX (24 years). CIMCX (1.35) is less costly to investors than BDHIX (0.87). BDHIX is a more actively managed with annual turnover of: 148.00 vs. CIMCX (65.00). CIMCX has a lower initial minimum investment than BDHIX: CIMCX (250) vs BDHIX (2000000). BDHIX annual gain was more profitable for investors over the last year : 13.59 vs. CIMCX (8.06). BDHIX return over 5 years is better than : 24.93 vs. CIMCX (20.12).
BDHIXCIMCXBDHIX / CIMCX
Total Expense Ratio0.681.3550%
Annual Report Gross Expense Ratio0.871.3564%
Fund Existence12 years24 years-
Gain YTD4.9865.65488%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.6B147B1%
Annual Yield % from dividends7.592.73279%
Returns for 1 year13.598.06169%
Returns for 3 years41.0833.07124%
Returns for 5 years24.9320.12124%
Returns for 10 years88.1467.70130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C